Synthetic Artificial Intelligence (AI) is emerging as a revolutionary solution that promises to compress these timelines while enhancing data quality and ensuring compliance with rigorous safety standards. This eBook delves into how synthetic AI is reshaping drug discovery and clinical development, supported by recent 2024-2025 data, research insights, and examples.
synthetic AIDrug Discovery and Compliance
Clinical Trials Are Too Slow! Discover How Synthetic AI Expedites Drug Discovery and Compliance
Each year, millions of patients around the world await new, life-saving therapies; yet the drug development process remains painfully slow. Clinical trials alone traditionally take 7-10 years to complete, costing upwards of $2 billion, with failure rates of around 85-90% for investigational drugs. This prolonged timeline costs lives, innovation momentum, and enormous financial resources.
About This Ebook:
Fill Out Your Details Below
We'll send the ebook directly to your email.
By downloading, you agree to receive updates about our products and services.